key: cord-0882178-tj2289l8
authors: Tanner, Caroline M.; Goldman, Samuel M.
title: EPIDEMIOLOGY OF PARKINSON'S DISEASE
date: 1996-05-01
journal: Neurologic Clinics
DOI: 10.1016/s0733-8619(05)70259-0
sha: 32f1b31d632b2344f199c335ac2cad10ff864587
doc_id: 882178
cord_uid: tj2289l8

nan

prevalence. Prolonged survival of persons with disease causes an actual increase in prevalence. Ideally, incidence and prevalence are determined by screening entire populations defined by specific geographic or political boundaries: community-or population-bused Estimates of prevalence based on populations identified by other methods, such as participants in a hospital clinic, do not reflect accurately the general population of an area, as cultural, economic, or other factors may influence case selection (selection bias).

Investigations of risk factors for disease may be prospective or cross-sect i~n a l . "~ Prospective cohort or follow-up studies identify unaffected persons who differ with respect to a specific factor proposed to be related to the disease (an exposure). These individuals are observed over time, and the frequency of new disease in exposed and unexposed persons is determined. PD is an uncommon disorder beginning in late life. The latency from onset of neurodegeneration to onset of clinical signs is unknown. In such a situation, prospective cohort studies are problematic because a large number of unaffected individuals must be followed for decades. Cross-sectional methods, such as case-control studies, are faster and more economical. In case-control studies, individuals already affected with the disease of interest are compared to individuals without the illness, and exposures proposed to relate to the illness are compared. The retrospective nature of case-control studies makes them prone to recall bias, whereby cases have improved or altered recall of past exposures relative to controls, the result of heightened vigilance in association with the diagnosis of a chronic illness. Finally, in some cases (such as toxicant-induced parkinsonism), identification and intensive investigation of an unusually high incidence of disease, either in space or in time (a cluster), may provide important clues to disease etiology.

There is no antemortem diagnostic test for PD. Consequently, diagnostic accuracy is a challenge in epidemiologic studies of PD. The most reliable antemortem diagnostic method is expert neurologic examination. Although autopsy diagnosis is definitive, this long follow-up has not been possible in any published epidemiologic study of PD. Because differing diagnostic methods can result in differences in the persons studied, these methods should be reviewed critically in all epidemiologic studies of PD. For example, the level of expertise of the diagnosticians can affect diagnostic accuracy dramatically. In some communities, essential tremor accounted for 10% to 40% of the false-positive diagnoses of Io4 Conversely, bona fide PD may be misdiagnosed as depression or, in the very elderly, "normal" aging. Neurodegenerative disorders, such as progressive supranuclear palsy or multiple system atrophy, may not be distinguished easily from PD early in the course of illness. 77 Temporal differences in diagnostic practices also can limit comparability across studies. Many of the neurodegenerative disorders with multiple system involvement and parkinsonism generally were recognized only in the last several decades. These may have been included in earlier studies of PD. Some cases classified as arteriosclerotic parkinsonism in the past today might be considered typical PD.I5, 93 In other reports, parkinsonism of known cause (drug-induced parkinsonism and postencephalitic parkinsonism) were grouped along with PD in determining incidence or prevalence rates.15, Ro, 116 Because these three types of parkinsonism are distinct, such a grouping could result in erroneous conclusions about disease patterns or risk factors.

James Parkinson's 1817 report of six cases"O preceded the first communitybased investigations of disease frequency by one and one half centuries. In 1958, KurlandBO reported an estimated combined prevalence of 187 per 100,000 for postencephalitic, arteriosclerotic, and nonarteriosclerotic parkinsonism in the population of Rochester, Minnesota. Annual disease incidence was estimated to be 20 per 100,000 persons. Case identification was performed through the records linkage system of the Mayo Clinic. Those residents not seeking medical care would have been missed by this method. Because PD has significant associated disability, however, most cases were likely identified. In 1967, Gudm u n d s s~n~~ identified PD cases in Iceland by physicians' reports and personal examination, estimating a combined annual incidence of 16 per 100,000 cases for arteriosclerotic and nonarteriosclerotic parkinsonism. Estimated prevalence for these two disorders was 162 per 100,000, an estimate similar to that for Rochester, Minnesota. Numerous subsequent surveys have used variations on these methods with a variety of available health care records (e.g., national health registries; pharmacy rosters; hospital and chronic care facility rosters; questionnaires directed to physicians, nurses, and social workers.) to identify persons with PD.* All of these studies would have missed early cases and cases not receiving medical care.1o3, lz9 Pharmacy drug-sale rosters have been shown to overestimate PD prevalence, especially in w0men.2~ Diagnostic errors, therefore, could have caused increased or decreased inclusion of actual cases. Results from many of these are shown in Table 1 .

A potentially more accurate method for determining disease frequency in a community involves a door-to-door survey of all households. Because such studies are time-and cost-intensive, often only those groups at higher risk of disease are studied. For example, only persons older than a certain age have been evaluated in surveys of populations interested in PD. Persons identified by a screening method as possibly suffering from a specific disorder then are referred for expert evaluation. Door-to-door surveys are costly, but a number of such surveys have been performed successfully, often in association with a national census.', l2, 87* Io3, lz3, 129, 153 Results of these surveys are presented in Table 2 .

Estimates of disease prevalence vary widely, from 31 per 100,000 in Libya6 to 328 per 100,000 in the Parsi community in Bombay, India." Although methodologic differences and population age distributions may explain some of this variation, even after adjusting for many of these inconsistencies, geographic prevalence differences persist.160 Several North American studies also have found significant regional differences in prevalence, with a suggestion of northwest to southeast gradients in both Canada and the United States.", w 137 It is possible that different distributions of factors related to PD causes across populations may contribute to geographic differences in disease frequency. These factors could include genetic differences in susceptibility to disease, differences in exposure to causative factors, and differences in exposure to protective factors.

A number of studies have attempted t o look at changes in the frequency of PD over time, searching for temporal patterns that could provide important etiologic clues. For example, an increasing incidence over time that correlates with the industrialization of a region could implicate industrial chemicals o r A review of Olmstead County data found no sigruficant change in PD incidence over the relatively brief period from 1967 through 1979. 117 Zhang et allw reviewed a number of incidence studies, age adjusting them to a single population, and detected no change in incidence rates over the past 50 years. Changes in disease frequency over long periods, however, are very difficult to measure reliably because of changes in and inconsistent application of diagnostic criteria. Additionally, many studies rely on death record analysis for ascertaining cases, introducing great variability owing to the inconsistent reporting of PD as a cause of death. Their shortcomings acknowledged, these studies show consistent dramatic changes in PD-related mortality. During the past 2 to 3 decades, irrespective of geographic location, death rates have fallen for those younger than age 65 and increased in those older than age 75.24,26,64, 83,146, 150 These observations are compatible with improved survival due to levodopa therapy, with mean age at death increasing approximately 5 years during the past 20 yearsE3, 149 Changes in PD incidence and mortality (after adjustment for population aging) could reflect improved diagnosis or improved record-keeping, or might reflect relative changes in mortality from other competing diseases, such as stroke and heart disease.lZ1, I z z

Increasing age is the only unequivocal risk factor for PD. PD incidence increases with increasing age throughout the life span.116 This is true in all community-based studies, regardless of the absolute prevalence of disease in the population.zO, 57, 94, 9*, '04, lz4, 136 Some examples of age-specific prevalence in different communities are shown in Figure 1 . The reasons for this relationship are not known. Possible explanations for the near exponential correlation between increasing age and PD prevalence include age-related neuronal vulnerability or a causal mechanism dependent on the passage of time.

Because of the strength and consistency of this risk factor, comparisons of disease frequency among populations must be adjusted for their differing age distributions.160 One would expect crude (unadjusted) PD incidence and prevalence to be higher in a community with a greater proportion of elderly individuals. Similarly, evaluation of any putative risk factor requires concomitant adjustment for the distribution of that risk factor with respect to age.

Because of their greater longevity, women constitute an increasing percentage of the population as age increases. For this reason, if risk is equal, one would expect the crude prevalence of PD to be greater in women. Age-adjusted or age-specific prevalences are more useful statistics for understanding potential causes of PD (ie., at a given age, what is the likelihood that an individual will have PD?). Although by no means a universal finding, an increasing percentage of studies find men to have a modestly increased age-adjusted PD prevalence.* This trend also persists across races,@, 89, 98 particularly in China, where the male-to-female ratio ranges from 2.4 to 3.7." 87, w 153 Examples of age-adjusted prevalence ratios by gender are shown in Table 3 lence in men is a function of biology or of male-related lifestyle factors is not clear. Further investigation of factors underlying these foci of increased male prevalence may provide important clues to the cause of PD.

PD prevalence generally appears to be highest in Europe and North America, whereas rates in Japan, China, and Africa are markedly lower (see Tables 1 and 2 ). Similarly, one community-basedq8 and several hospital-based series in the United States and Africa found PD prevalence to be much lower among blacks.n,108,1W These observations suggest that there is a greater risk for PD among whites. Other differences among the populations studied, however, such as underlying age distribution and use of medical care, also could cause such differences in prevalence. Exceptions to the above findings are two doorto-door studies-ne performed in Copiah County, Missi~sippi,'~~ and the other in a Parsi colony in Bombay, India.I2 Prevalence in Copiah County was similar between whites and blacks, if cases were chosen using the least stringent diagnostic criteria (i-e., possible Parkinson's disease), although whites continued to have higher prevalence if more rigorous criteria (i.e., probable Parkinson's disease) were used to identify cases. In the Parsi community in Bombay, prevalence was similar to that found in Europe and North America. The Parsis are Persian descendants who migrated to India between the seventh and tenth centuries. They formed a closed community into which conversion is impossible. These facts may account for the high prevalence observed, despite their Asian residence.

Although socioeconomic or environmental factors may explain the prevalence differences cited here, a still-to-be-refuted possibility is that PD is more common in whites, most likely as the result of a common genetic characteristic.

Heredity is another commonly identified risk factor for PD. First, many examples of familial parkinsonism have been reported. Several kindreds with multiple members with apparent autosomal-dominant parkinsonism have been but most of these studies are limited by their reliance on familyderived histories for deceased relatives. In addition, the clinical and pathologic features of the majority of described kindreds are not fully consistent with those Maraganore et alyl studied the first-degree relatives of 20 British PD patients who reported at least one additional family member with PD. Examinationverified idiopathic PD indistinguishable from sporadic PD was found in 13 of 69 living first-degree relatives, leading the authors to propose an autosomaldominant pattern of inheritance with reduced penetrance. Payami et studied PD frequency in 586 first-degree relatives of 114 PD patients ascertained from a movement disorder clinic and in a similar number of controls. All affected relatives had been diagnosed by a community physician. Relatives of PD patients were 3.5 times more likely to have PD than relatives of controls, again suggesting an autosomal-dominant pattern. Notwithstanding their possible significance, it must be emphasized that neither of these studies used population-based methods, and it cannot be assumed that these findings are generalizable to the population at large. Additionally, these studies assess the probability of a positive family history of I'D given that the proband has I'D, when the real question regards the probability of PD given a positive family history.

Other studies support a less prominent role for genetic factors, postulating multifactorial inheritance with symptoms dependent on environmental factors." 79, 93, 101 Twin studies further support a less prominent contribution of genetic factors in I'D, as concordance rates between monozygotic and dizygotic twins are similar?" 96,

In classic autosomal-dominant disorders, monozygotic twins show much higher concordance than do dizygotic twins. PD, however, is a disorder of late life. If onset age differs sigrulicantly between twins, and one twin dies before symptoms are apparent, genetically concordant twins may appear to be discordant. A recent positron emission tomography (PET) scan study by B u m et all8 supports this possibility. They looked at putamenal I8Fdopa uptake in twin pairs discordant for PD clinically and found that 30% to 40% of asymptomatic cotwins had significantly decreased uptake. Similar PET scan results were reported recently by Piccini et al.Il3 Concordance rates for decreased 18F-dopa uptake, however, did not differ for monozygotic and dizygotic twins, arguing against a classic Mendelian autosomal-dominant cause of this observation. Moreover, the relationship between this radiographic finding and subsequent clinically or pathologically diagnosed PD is unknown. Neither is the population prevalence of decreased putamenal lRF-dopa uptake well understood. Prospective observation of these and other cases will be useful in determining the significance of these interesting findings. of typical PD~34,50.100,125,156

Consistent with multifactorial theories of PD etiology, several genes that code for metabolic enzymes have been identified that may contribute to PD risk. Variant alleles for cytochrome P450 isoenzyme CYP2D6: 5, 78, 132, 147 and several specific monoamine oxidase haplotypes6'. 82 occur with increased frequency in individuals with PD, although these associations are not reported universally.*' These variants potentially could result in toxic effects from levels of some endogenous or exogenous compounds that might not otherwise be toxic (i.e.,

It is hoped that the role of genetic factors in PD etiology will be clarified soon, as the rapid development of molecular genetic technology has focused much attention on this question.

The idea that exposure to an exogenous agent might cause PD was triggered by the observation of a cluster of parkinsonism caused by the intravenous injection of the compound l-methyl-1,2,4,6-tetrahydropyridine (MPTP) by narcotics

Prior to this discovery, parkinsonism was known to result from numerous chemical but MPTP-induced parkinsonism is remarkable in that it strictly mimics the anatomic and clinical features of PD rather than causing more widespread CNS injury. This observation sparked a search for naturally occurring environmental factors that might be causally related to idiopathic PD. One key aspect to the search for environmental causes of PD, in contrast to MPTP, is that signs of idiopathic PD develop very gradually. Substances that are mildly toxic, or which ingress or accumulate in the brain slowly, are difficult to evaluate, and their significance could be missed.1a

International differences in PD prevalence could be explained by international differences in toxicant exposure. PD appears to be less common in countries more recently industrialized. Studies using antiparkinsonian drug sales to estimate prevalence found vegetable farming, wood pulp mills, and steel alloy industries in areas with the highest disease prevalence." Very similar results were found in a Michigan ecologic study using county-specific PD mortality rates,lz6 where significantly higher rates were found in counties with paper-, chemical-, iron-, or copper-related industries.

found an association between young age at PD onset and residence in rural Saskatchewan, and Tanner et found a similar association in a Chicago-based clinical series. These observations have been tested in numerous case-control and ecologic studies.* Many of these are summarized in Table  4 . Although both the methods used and the locations of these studies have differed, all show an association between at least one of the proposed exposures-rural residence, farming, well water drinking, or herbicide/pesticide exposure-and an increased risk for developing PD. Hubble et alG used a multiple logistic regression model to discern that most of the associations they observed were in fact a function of their relationship to pesticide use.

The structural and mechanistic resemblance of some common agricultural chemicals to the toxin MPTP3, Io6, 119 is particularly intriguing. The significance of these associations should be weighed cautiously, however. All of the studies previously described are limited by small size, and differing methods prevent direct comparisons. Although reproducibility of the associations over many different studies lends strength to the observations, a cause/effect relationship cannot be assumed. Much further collaborative work between clinicians, epidemiologists, and laboratory scientists is necessary to clarlfy the import of the association between rural residence or its associated factors and PD.

The observation that parkinsonism was a common late sequela of encephalitis lethargica, a disorder that was pandemic in the second and third decades of this century, prompted the postulate that all cases of parkinsonism were the result of exposure to that infectious agent. 114 The corollary prediction that PD ultimately would disappear now has been proved incorrect as survivors of that epoch died, and few cases of parkinsonism today are thought to be postencephalitic. One studyg7 suggested that in utero exposure to influenza virus may cause a loss of nigral neurons and consequent increased vulnerability to PD, but this observation was not confirmed. 35 Fazzini et Many attempts to identify an infectious agent in PD failed.36,95* a141 found increased cerebral spinal fluid (CSF) antibody titers to coronaviruses in persons with PD. Specific coronaviruses have an affinity for basal ganglia in some animals, and members of this species commonly affect agricultural animals such as pigs. Hubble et aP2 and Kohbata et al" found increased Nocardia antibody titers in PD patients, and Nocurdia can cause a levodopa-responsive movement disorder in mice associated with its specific affinity for substantia nigral neurons.'O, 74 Rather than reflecting an exposure to an environmental chemical, the increased risk of developing PD associated with rural residence may reflect environmental exposure to an infectious agent.

Retrospective case-control studies often report an association between head trauma and PD.I3, 32, 38, 135, 141 Studies comparing prospectively collected information (that is, information collected before the person got PD), however, do not find this ass~ciation."~, 157 Patients with a chronic illness typically seek explanations for their disease in prior experiences, and those with CNS injuries might be particularly thoughtful about head injuries. A similar pattern of recall is seen in other neurologic diseases, such as Alzheimer's disease, in which prospectively collected information shows no association between head injury and disease, but retrospectively collected information typically suggests that head trauma is associated with Alzheimer's disease. 21 It is most likely that the reported association between head trauma and PD reflects biased recall, rather than a cause/ effect association. Consistent with this conclusion, Goetz et a147 in 1991 found that PD patients who sustain head trauma have no change in the long-term course of their disease. Unless prospectively collected information shows such an association, trauma should not be considered to increase the risk for PD.

Both CharcoP and G o w e r~~~ cited stress as a possible cause of PD. Laboratory studies suggest that stress-produced changes in central dopamine systems theoretically could contribute to the development of parkins~nism.'~~, 134 Similarly, persons already affected with PD experience transient worsening of their symptoms during stressful periods." Two reports linked the extreme emotional and physical hardship of concentration camp imprisonment with the subsequent development of 146 Whether these observations reflect an accelerated nigral injury as the result of stress-related increase in dopamine turnover with resultant increased oxidative injury, nutritional deficiencies of dietary protective agents, or other factors cannot be determined. Evaluation of the relationship of less severe emotional or physical stress to the development of PD poses a methodologic challenge.

Oxidative mechanisms have been proposed to be involved in the pathogenesis of PD, and, in consequence, intake of antioxidant vitamins has been proposed to protect against the development of PD.17, 27, 40 Patients with vitamin E defi-ciency show reduced putamenal 18F-dopa uptake in PET scans,Bo although no differences have been found in serum42 or in brain tocopherol levels31 in patients with I' D. Consumption of foods rich in tocopherol decreased the risk of developing PD in two case-control studies, one comparing PD cases to same-sex siblings and one comparing subjects to spouses.48, 51 The use of supplemental multivitamins, vitamin E, or cod liver oil was associated similarly with a decreased risk for PD,1" although the ability of vitamin E supplements to slow progression of already diagnosed PD is inconcl~sive.~~, 86 No significant differences between cases and controls in dietary intake of vitamins E or C, betacarotene, protein calories, or total calories were found in a Chinese pop~lation,'~~ but the tocopherol content of many of the foods commonly eaten in China was not available, so this negative result simply could reflect inadequate information.

Although the numbers studied to date are small, these studies suggest that eating foods rich in tocopherol or some associated behavioral or dietary factors may protect against the development of I'D in some cases. These observations allow the suggestion that areas with a low prevalence of PD may not be those with a lesser concentration of environmental toxins but rather those in which there is higher dietary intake of protective substances or a lower dietary intake of pro-oxidants. This latter possibility is supported by a recent case-control study that found increased animal fat intake in PD cases relative to controls?"

A study of US military veterans in the late 1960s resulted in the observation of an inverse association between smoking and I'D. 70 The low prevalence of cigarette smoking among prevalent cases of PD is an observation confirmed in numerous subsequent case-control studies in the United States and Europe? 13, 16, 32, 44, 56, 68, 73* 105, 143, ls4 and recently in a large prospective study in Hawaii, where a modest dose-response relationship was 0bserved.5~ Most of these studies found an odds ratio of approximately 0.5 for ever-versus-never having smoked. Five studies, however, found no association between smoking and PD.", 99, 118, 140 Two of these studies, performed in China or Hong Kong, raise questions concerning any protective effect of cigarette smoking. Smoking is extremely rare among Chinese women but relatively common among men, but PD occurs in Chinese men nearly four times more often than in Chinese women.87, 14" If smoking exerted a true biologic protective effect, a higher prevalence of PD would be expected in the nonsmoking Chinese women than in men.

The proposed protective effect of cigarette smoking could be confounded by many factors, including a greater propensity for persons to quit smoking because they are becoming ill even before being diagnosed99 and the possibility that patients with I'D who smoke have greater mortality than those patients who do not ~m o k e ?~,~~~ Rather than reflecting an actual biologic action, decreased smoking in PD simply could reflect the more conservative personality that may accompany PD13,48*111 (i.e., smoking behavior could be a reflection of an underlying process, rather than the cause of that process). Nonetheless, given the consistency and strength of the inverse association and the suggestion of a dose-response relationship in a large prospective study, the bulk of epidemiologic evidence supports a potentially protective effect of cigarette smoking on PD risk. Coupled with studies demonstrating protective effects of nicotine on age-, transection-, and MPTP-induced dopaminergic neuronal cell loss in rodent substantia nigra,ffi, the evidence further supports the possible protective role of smoking on PD risk.

The epidemiologic studies reviewed here have provided insights into the etiology of PD. Evidence increasingly suggests that, like many other chronic age-related diseases, PD is a multifactorial disorder, with both genes and environment contributing to risk. As the elderly population of the world grows, incidence a n d prevalence of I'D will continue to increase, underscoring the importance of further delineating risk factors. The introduction of levodopa and other pharmacologic therapies over the last 2 decades has postponed disease morbidity and mortality, b u t morbidity and mortality still are increased markedly relative to unaffected individuals. The development of therapies that may slow disease progression makes early identification and treatment of PD particularly important. Investigations of early markers of I'D, or markers of disease susceptibility, are critical areas for future research. These efforts all will b e aided b y careful collaboration between epidemiologists and laboratory scientists.

Prevalence of Parkinson's disease and essential tremor i n a village of south Spain

Association between the oxidative polymorphism and early onset of Parkinson's disease

Role of N-methvltransferases in the neurotoxic

ity associated with the metabolites of l-methyl-4-phenyl-l,2,3,6-tetrahydropyridine (MPTP) and other 4-substituted pyridines present in the environment

A Swedish county with unexpectedly high utilization of anti-parkinsonian drugs

Mutant debrisoquine hydroxylation genes in Parkinson's disease

New data on the genetics of Parkinson's disease

Uneven prevalence of Parkinson's disease in the province of Quebec

Cigarette smoking and Parkinson's disease: I. A comparison of cases with matched neighbors

Mechanisms of interactions in the murine brain-a review

Birthplace as a risk factor in motor neurone disease and Parkinson's disease

Prevalence of Parkinson's disease in the Parsi community of Bombay

A case-control study of twin pairs discordant for Parkinson's disease: A search for environmental risk factors

Risk factors for Parkinson's disease: A population-based case-control study

Neurological disease in an English city

Cigarette smoking and Parkinson's disease

Parkinson's disease: A chronic, low-grade antioxidant deficiency? Med Hypotheses 0111-114

et a1 Parkinson's disease in twins studied with 18F-dopa and positron emission tomography

Etiology of Parkinson's disease: Results of two case-control studies

Is the prevalence of Parkinson's disease in New Zealand really changing?

Head trauma with loss of consciousness as a risk factor for Alzheimer's disease

Lectures on the Diseases of the Nervous System

An analysis of 215 patients

Parkinson's disease mortality in Italy

Prevalence of Parkinson's disease in a district on northern Italy: Comparison between tracer and traditional methodologies

Mortality from Parkinson's disease in England and Wales 1921-89

et a1 Oxygen radicals and human disease

PrevaIence of Parkinson's disease in the republic of San Marino

Davanipour 2, Will A D Residential histories in Parkinson's disease patients

Nigrostriatal function in vitamin E deficiency: Clinical, experimental, and positron emission tomographic studies

Alpha-tocopherol levels in brain are not altered in Parkinson's disease

The epidemiology of Parkinson's disease: A case-control study of young-onset versus old-onset patients

The genetics of Parkinson's disease

et a1 Dominantly inherited, early-onset parkinsonism: Neuropathology of a new form

Does idiopathic parkinsonism in Aberdeen follow intrauterine influenza?

The viral hypothesis in Parkinson's disease in Alzheimer's disease: A critique

Differential postmorbidity mortality in observational studies of risk factors for neurologic disorders

Prior history of head trauma in Parkinson's disease

Fahn S A pilot trial of high-dose alpha-tocopherol and ascorbate in early Parkinson's disease

The oxidant stress hypothesis in Parkinson's disease: Evidence supporting it

Cerebrospinal fluid antibodies to coronaviruses in patients with Parkinson's disease

Serum levels of alphatocopherol (vitamin E) in Parkinson's disease

Neurological disease in ex-Far-East prisoners of war

Marmot MG, et a1 Smoking and Parkinson's disease

Motor vehicle accident and Parkinson's disease disability

Stebbins G T Effects of head trauma from motor vehicle accidents on Parkinson's disease

Smoking and Parkinson's disease: Search for a dose-response relationship

Davis P H Case-control study of early life dietary factors in Parkinson's disease

Davis P H Follow-up study of early life protective and risk factors in Parkinson's disease

A large kindred with autosomal dominant Parkinson's disease

Gowers WR: Diseases of the Nervous System

Prospective study of cigarette smoking and the risk of developing idiopathic Parkinson's disease

A clinical survey of parkinsonism in Iceland

Nicotine exposure and Parkinson's disease

Epidemiology of Parkinson's disease in a Japanese city

Parkinson's disease: A case-control study of occupational and environmental risk factors

A case-control study of Parkinson's disease in a horticultural region of British Columbia

Epidemiologic study of Parkinson's disease in Hong Kong

Hereditary variations in monoamine oxidase as a risk factor for Parkinson's disease

Nocardia serology in Parkinson's disease

Risk factors for Parkinson's disease

Rising mortality from Parkinson's disease in Japan

Chronic nicotine treatment counteracts nigral cell loss induced by a partial mesodiencephalic hemitransection: An analysis of the total number and mean volume of neurons and glia in substantia nigra of the male rat

Differential effects of acute and chronic nicotine treatment on MPTP-(l-methyl-4-phenyl-l,2,3,6-tetrahydropyridine) induced degeneration of nigrostriatal dopamine neurons in the black mouse

Epidemiology of parkinsonism in Victoria

Premorbid smoking, alcohol consumption, and coffee drinking habits in Parkinson's disease: A case-control study

Exposure to well water drinking and pesticides in Parkinson's disease. A case-control study from the southeast area of Madrid

The Dorn Study of smoking among US veterans. In National Cancer Institute, Epidemiologic Approaches to the Study of Cancer and Other Diseases

Epidemiologic studies of Parkinson's disease. 11. A hospital-based survey

Epidemiologic studies of Parkinson's disease. III. A community-based survey

Epidemiologic studies of Parkinson's disease. I. Smoking and Parkinson's disease: A survey and explanatory hypothesis

L-dopa-responsive movement disorder caused by Nocardia

Circulating antibody to Nocardia in the serum of patients

Environmental risk factors in Parkinson's

Classification of Parkinsonism

Debrisoquine hydroxylase and Parkinson's disease

Parkinson's disease: Genetic analysis and evidence of a multifactorial etiology

Epidemiology: Incidence, geographic distribution and genetic considerations

et a1 Lack of association of CYP2D6 and MAO-B alleles with Parkinson's disease in a Kansas cohort

Association of a monoamine oxidase B allele with Parkinson's disease

The changing patterns of death rates in parhnsonism

Parkinsonism death rates by race, sex, and geography

et a1 Chronic parkinsonism in humans due to a product of meperidine-analog synthesis

Clinical trials of neuroprotection in Parkinson's disease: Long-term selegiline and alpha-tocopherol treatment

A prevalence s w e y of Parkinson's disease and other movement disorders in the People's Republic of China

Projected neurodegenerative disease mortality in the United States

Two decades of increasing mortality from Parkinson's disease among the US elderly

A case-control study of diet and Parkinson's disease (PD): Calories, lipids and antioxidants

A clinical and genetic study of familial Parkinson's disease

Twins and Parkinson's disease

Parkinson's disease: A genetic study

Epidemiology of Parkinson's disease in Finland

Infect Immun 59181-191,1991 with Parkinson's disease

Could Parkinson's disease follow intrauterine influenza?: A speculative hypothesis

A population-based investigation of Parkinson's disease with and without dementia

Smoking and Parkinson's disease

Familial parkinsonism and dementia with ballooned neurons

Mjones H Paralysis agitans: A clinical and genetic study

Risk factors for Parkinson's disease: Case-control study in the province of Caceres, Spain

Prevalence of Parkinson's disease and other types of parkinsonism: A door-to-door survey in three Sicilian municipalities

Parkinson's disease in a Scottish city

A retrospective study of smoking and Parkinson's disease

Inhibition of NADH-linked oxidation in brain mitochondria by MPP', a metabolite of the neurotoxin MPTP

Prevalence of Parkinson's disease in Izumo City

The pattern of neurological illness in tropical Africa: Experience at Ibadan, Nigeria

Occurrence of Parkinson's disease in black patients at Charity Hospital in New Orleans

An Essay on the Shaking Palsy

Is there a premorbid personality typical for Parkinson's disease?

Increased risk of Parkinson's disease in parents and siblings of patients

et a1 Dopaminergic function in relatives of Parkinson's disease patients: A clinical and PET study

Further observations on the cohort phenomenon in Parkinson's syndrome

et a1 Chronic nicotine intake decelerates aging of nigrostriatal dopaminergic neurons

A case-control study of smoking habits, dementia, and other illnesses in idiopathic Parkinson's disease

Epidemiology of parkinsonism: Incidence, classification and mortality

Stem W, et a1 Early onset of Parkinson's disease in Saskatchewan: Environmental considerations for etiology

Energy driven uptake of MPP' by brain mitochondria mediates the neurotoxicity of MPTP

Cigarette smoking and Parkinson disease: The illusion of a neuroprotective effect

The nonenvironmental basis for rising mortality from Parkinson's disease

Rising mortality due to Parkinson's disease and amyotrophic lateral sclerosis: A manifestation of the competitive nature of human mortality

Prevalence of Parkinson's disease and other parkinsonisms: A door-to-door survey in two Sicilian communities

The risk of Parkinson disease in Mediterranean people

Familial parkinsonism, apathy, weight loss, and central hypoventilation: Successful long-term management

Parkinson's disease mortality and the industrial use of heavy metals in Michigan

Case-Control Studies: Design, Conduct, Analysis

Schoenberg BS Descriptive epidemiology of Parkinson's disease: Disease distribution and hypothesis formulation

Haerer A F Prevalence of Parkinson's disease in the biracial population of Copiah County

Comparison of the prevalence of Parkinson's disease in black populations in the rural US and in rural Nigeria: Doorto-door community studies

Parkinson's disease and exposure to agricultural work and pesticide chemicals

Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease

Stress-induced neurological impairments in an animal model of parkinsonism

Dopamine turnover and glutathione oxidation: Implications for Parkinson's disease

The epidemiology of Parkinson's disease

Parkinson's disease in the district of the Northampton Health Authority, United Kingdom

Geographic variations in the prevalence rates of Parkinson's disease in Alberta

Occupation and the risk of Parkinson's disease: A case-control study in young onset patients

et a1 Dietary antioxidant vitamins and the risk of developing Parkinson's disease

Environmental factors and Parkinson's disease: A case-control study in China

Environmental factors in the etiology of Parkinson's disease

Vitamin use and Parkinson's disease

Cigarette smoking, alcohol drinking and Parkinson's disease: Cross-cultural risk assessment

Metabolic aspects of the behavior of MPTP and some analogues

Prevalence of Parkinson's disease in the elderly: A population study in Gironde

Case-control study, with use of temporal approach, for evaluation of risk factors for Parkinson's disease

A novel cytochrome P-450IID6 mutant gene associated with Parkinson's disease

Parkinsonism survival in the Levodopa era

Levodopa therapy and survival in idiopathic Parkinson's disease: Olmsted County project

Mortality rates for Parkinson's disease and parkinsonism in Italy

Parkinson's disease in twins

Parkinson's disease in twins

A community survey by neurologists

A case-control study on the environmental risk factors of Parkinson's disease in Tianjin

Parkinson's disease in 65 pairs of twins and in a set of quadruplets

Autosomal dominant lewy body parkinsonism in a fourgeneration family

Brain injury and neurologic sequelae

Environmental risk factors in siblings with Parkinson's disease

Facteurs environnementaux dans l'etiologie de la maladie de Parkinson

Worldwide occurrence of Parkinson's disease: An updated review

et a1 Parkinson's disease in monozygotic twins: A followup

Addvess reprint requests to

MD The Parkinson's Institute 1170